Market Introduction
Kidney disease is also known as renal disease. It is caused due to the malfunctioning of the kidney. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others. For the treatment and diagnosis of these types of diseases, different global and regional players are offering various products and services.
Market Overview and Dynamics
TheNorth Americakidney disease market is expected to reach US$ 42,462.1 million in 2027 from US$ 25,483.5million in 2019. The market is estimated to grow with a CAGR of 6.7% from 2020-2027. The growth of the market is attributed to some key driving factors such asan increasing prevalence of chronic kidney related diseases and a high growth in aging population. However, the market is expected experiencing slow growth during the forecast period owing to failure in diagnosing cases of kidney diseases.
Key Market Segments
Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.
Major Sources and Companies Listed
Some of the major primary and secondary sources forkidney disease market included in the report are American Urological Association, National Kidney Foundation,Kidney International Report, and others.
Reasons to buy the report
NORTH AMERICA KIDNEY DISEASE MARKET SEGMENTATION
· Diagnosis
o Blood Tests
o Urine Tests
o Imaging Tests
o Others
· Treatment
o Dialysis
o Others
o Drug Class
§ ACE Inhibitors
§ Angiotensin-II Receptor Blockers
§ Diuretics
§ Others
· Hospitals
· Diagnostic Laboratories
· Others
· North America
o US
o Canada
o Mexico
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 25,483.5 Million |
| Market Size by 2027 | US$ 42,462.1 Million |
| CAGR (2020 - 2027) | 6.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
The North America Kidney Disease Market is valued at US$ 25,483.5 Million in 2019, it is projected to reach US$ 42,462.1 Million by 2027.
As per our report North America Kidney Disease Market, the market size is valued at US$ 25,483.5 Million in 2019, projecting it to reach US$ 42,462.1 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
The North America Kidney Disease Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Kidney Disease Market report:
The North America Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Kidney Disease Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For North America Kidney Disease Market
